Disease stages and therapeutic hypotheses in two decades of neurodegenerative disease clinical trials by Meredith A. Mortberg, Sonia M. Vallabh, Eric Vallabh Minikel

Get full text

Analysis of non-human primate models for evaluating prion disease therapeutic efficacy. by Meredith A Mortberg, Eric Vallabh Minikel, Sonia M Vallabh

Get full text

Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease by Sonia M. Vallabh, Eric Vallabh Minikel, Victoria J. Williams, Becky C. Carlyle, Alison J. McManus, Chase D. Wennick, Anna Bolling, Bianca A. Trombetta, David Urick, Chloe K. Nobuhara, Jessica Gerber, Holly Duddy, Ingolf Lachmann, Christiane Stehmann, Steven J. Collins, Kaj Blennow, Henrik Zetterberg, Steven E. Arnold

Get full text

Regional variability and genotypic and pharmacodynamic effects on PrP concentration in the CNS by Meredith A. Mortberg, Hien T. Zhao, Andrew G. Reidenbach, Juliana E. Gentile, Eric Kuhn, Jill O’Moore, Patrick M. Dooley, Theresa R. Connors, Curt Mazur, Shona W. Allen, Bianca A. Trombetta, Alison McManus, Matthew R. Moore, Jiewu Liu, Deborah E. Cabin, Holly B. Kordasiewicz, Joel Mathews, Steven E. Arnold, Sonia M. Vallabh, Eric Vallabh Minikel

Get full text